Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Arefian, Ehsan  [Clear All Filters]
Journal Article
Fazeli N, Arefian E, Irani S, Ardeshirylajimi A, Seyedjafari E. Accelerated reconstruction of rat calvaria bone defect using 3D-printed scaffolds coated with hydroxyapatite/bioglass. Sci Rep. 2023;13(1):12145.
Samimi H, Sohi ANaderi, Irani S, Arefian E, Mahdiannasser M, Fallah P, Haghpanah V. Alginate-based 3D cell culture technique to evaluate the half-maximal inhibitory concentration: an in vitro model of anticancer drug study for anaplastic thyroid carcinoma. Thyroid Res. 2021;14(1):27.
Hashemi J, Kajbafzadeh A-M, Ghorbani F, Soleimani M, Arefian E, Khorramirouz R, Enderami SEhsan, Pasalar P. Application of iPSCs Derived Pancreatic β-Like Cells Using Pancreatic Bio-Scaffold. Exp Cell Res. 2021:112667.
Jamshidi-Adegani F, Ghaemi S, Al-Hashmi S, Vakilian S, Al-Kindi J, Rehman NUr, Alam K, Al-Riyami K, Csuk R, Arefian E, et al. Comparative study of the cytotoxicity, apoptotic, and epigenetic effects of Boswellic acid derivatives on breast cancer. Sci Rep. 2022;12(1):19979.
Mirfazeli ESadat, Arefian E, Nadri S, Rezazadeh R, Kehtari M, Zeynali B. DKK1 expression is suppressed by miR-9 during induced dopaminergic differentiation of human trabecular meshwork mesenchymal stem cells. Neurosci Lett. 2019.
Nejati A, Shahmahmoodi S, Arefian E, Shoja Z, Marashi S-M, Tabatabaie H, Mollaei-Kandelous Y, Soleimani M, Nategh R. Efficient inhibition of human immunodeficiency virus replication using novel modified microRNA-30a targeting 3'-untranslated region transcripts. Exp Ther Med. 2016;11(5):1833-1838.
Ghaemi S, Arefian E, Valojerdi RRezazadeh, Soleimani M, Moradimotlagh A, Adegani FJamshidi. Inhibiting the expression of anti-apoptotic genes BCL2L1 and MCL1, and apoptosis induction in glioblastoma cells by microRNA-342. Biomed Pharmacother. 2019;121:109641.
Attari F, Keighobadi F, Abdollahi M, Arefian E, Lotfizadeh R, Sepehri H, Farimani MMoridi. Inhibitory effect of flavonoid xanthomicrol on triple-negative breast tumor via regulation of cancer-associated microRNAs. Phytother Res. 2020.
Oraee-Yazdani S, Akhlaghpasand M, Shokri G, Rostami F, Golmohammadi M, Jamshidi-Adegani F, Arefian E, Hafizi M, Zomorrod MSoufi, Oraee-Yazdani M, et al. Intracerebral Administration of Autologous Mesenchymal Stem Cells as HSV-TK Gene Vehicle for Treatment of Glioblastoma Multiform: Safety and Feasibility Assessment. Mol Neurobiol. 2021.
Alahverdi A, Arefian E, Soleimani M, Ai J, Yousefi-Ahmadipour A, Babaei A, Islam MShahidul, Ebrahimi-Barough S. Involvement of EGFR, ERK-1,2 and AKT-1,2 Activity on Human Glioma Cell Growth. Asian Pac J Cancer Prev. 2020;21(12):3469-3475.
Moradimotlagh A, Arefian E, Valojerdi RRezazadeh, Ghaemi S, Adegani FJamshidi, Soleimani M. MicroRNA-129 Inhibits Glioma Cell Growth by Targeting CDK4, CDK6, and MDM2. Mol Ther Nucleic Acids. 2019;19:759-764.
Banaei-Esfahani A, Moazzeni H, Nosar PNaseri, Amin S, Arefian E, Soleimani M, Yazdani S, Elahi E. MicroRNAs that target RGS5. Iran J Basic Med Sci. 2015;18(2):108-14.
Gheidari F, Arefian E, Adegani FJamshidi, Kalhori MReza, Seyedjafari E, Kabiri M, Teimoori-Toolabi L, Soleimani M. miR-424 induces apoptosis in glioblastoma cells and targets AKT1 and RAF1 oncogenes from the ERBB signaling pathway. Eur J Pharmacol. 2021:174273.
Taheri M, Tehrani HAbdul, Dehghani S, Alibolandi M, Arefian E, Ramezani M. Nanotechnology and bioengineering approaches to improve the potency of mesenchymal stem cell as an off-the-shelf versatile tumor delivery vehicle. Med Res Rev. 2024.
Honardoost M, Keramati F, Arefian E, Yeganeh SMohammadi, Soleimani M. Network of three specific microRNAs influence type 2 diabetes through inducing insulin resistance in muscle cell lines. J Cell Biochem. 2018.
Aghaee-Bakhtiari SHamid, Arefian E, Soleimani M, Noorbakhsh F, Samiee SMirab, Fard-Esfahani P, Mahdian R. Reproducible and Reliable Real-time PCR Assay to Measure Mature Form of miR-141. Appl Immunohistochem Mol Morphol. 2015.
Soufiani KBahman, Pourfathollah AAkbar, Zarif MNikougofta, Arefian E. Tumor Microenvironment Changing through Application of MicroRNA-34a Related Mesenchymal Stem Cells Conditioned Medium: Modulation of Breast Cancer Cells toward Non-aggressive Behavior. Iran J Allergy Asthma Immunol. 2021;20(2):221-232.